Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Rhythm Pharmaceuticals, Inc. < Previous 1 2 3 Next > Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old December 20, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to December 03, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide November 18, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology November 13, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants November 13, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences November 06, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update November 05, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024 November 04, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome October 24, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024 October 23, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants October 08, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants September 16, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old August 26, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September August 26, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants August 13, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update August 06, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old July 31, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity July 23, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 July 23, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants July 11, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer July 08, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency June 28, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants June 11, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024 June 03, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference June 03, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome May 22, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces New Employment Inducement Grants May 09, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update May 07, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting May 06, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology April 29, 2024 From Rhythm Pharmaceuticals, Inc. Via GlobeNewswire Tickers RYTM < Previous 1 2 3 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
